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Structural Differences in the DNA Binding Domains
of Human p53 and Its C. elegans Ortholog Cep-1
members of the p53 family in humans (Kaghad et al.,
1997; Schmale and Bamberger, 1997). All three proteins
are thought to have arisen from a common ancestor
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Philadelphia, Pennsylvania 19104 p53 family in evolution (Derry et al., 2001; Schumacher et
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Santa Barbara, California 93106 mouse p53 DNA binding domains (Cho et al., 1994; Zhao
et al., 2001). Unexpectedly, we found that certain struc-
tural features of human p53 that are important for se-
quence-specific DNA binding are not conserved inSummary
Cep-1.
The DNA binding domains of human p53 and Cep-1,
its C. elegans ortholog, recognize essentially identical Results
DNA sequences despite poor sequence similarity. We
solved the three-dimensional structure of the Cep-1 Alignment of the amino acid sequences of Cep-1 and
human p53 suggests that the DNA binding domain ofDNA binding domain in the absence of DNA and com-
pared it to that of human p53. The two domains have Cep-1 is located between residues 205 and 425 of the
full-length protein. However, due to poor sequence simi-similar overall folds. However, three loops, involved in
DNA and Zn binding in human p53, contain small  larity, the precise boundaries of the domain could not
be determined. We expressed and purified recombinanthelices in Cep-1. The helix in loop L3 of Cep-1 orients
the side chains of two conserved arginines toward proteins corresponding to residues 205–425, 216–420,
and 220–420 of Cep-1 and screened them for their abilityDNA; in human p53, both arginines are mutation hot-
spots, but only one contacts DNA. The  helix in loop to crystallize. The protein spanning residues 220–420
formed crystals that diffracted to 2 A˚ resolution. PhasesL1 of Cep-1 repositions the entire loop, making it
unlikely for residues of this loop to contact bases in were calculated using a mercury derivative, and a struc-
ture was solved in which residues 223–418 of Cep-1the major groove of DNA, as occurs in human p53.
Thus, during evolution there have been consider- are well defined (Table 1). We also attempted to obtain
crystals of Cep-1 bound to DNA; however, these effortsable changes in the structure of the p53 DNA binding
domain. were not successful.
Cep-1 adopts a  sandwich fold and contains key
structural elements present in human and mouse p53,Introduction
such as the Zn binding site, helix H2 that contacts the
major groove of DNA, and the  hairpin that lies betweenThe p53 tumor suppressor protein is a sequence-spe-
helix H2 and the  sandwich (Figures 1A and 1B). How-cific DNA binding transcription factor that induces cell
ever, there are also interesting differences. First, thecycle arrest or apoptosis in response to DNA damage
N-terminal end of the Cep-1 DNA binding domain is just(Vogelstein et al., 2000). In more than half of all human
N-terminal to strand S1, whereas human p53 has atumors, p53 function is inactivated by missense muta-
coil N-terminal to strand S1 that packs against severaltions that target its sequence-specific DNA binding do-
of the strands that form the  sandwich. The secondmain (Hollstein et al., 1991). The sequence-specific DNA
difference relates to loops L1, L2, and L3, which in hu-binding domain of p53 has high sequence similarity to
man p53 are involved in DNA and Zn binding. In humanthe DNA binding domains of p63 and p73, two other
p53, these loops do not contain secondary structure,
but in Cep-1, each of the loops contains a small segment
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that adopts an -helical conformation. We refer to theupenn.edu (E.S.S.)
 helices within loops L1, L2, and L3 as helices Ha, Hb,7 Present address: The Hospital for Sick Children, University of To-
ronto, Toronto, Ontario, Canada M5G 1X8. and Hc, respectively.
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ing different positions in the two proteins. In humanTable 1. Data Collection and Refinement Statistics
p53, the tip extends as far forward as helix H2, allowing
Data Collection
Lys120, the residue at the L1 tip, to contact a base in
Data set Native Mercury chloride the major groove of DNA (Figures 2A, 2C, and 3C). In
Space Group P212121 P212121 Cep-1, the corresponding residue, Lys237, is recessed
Resolution (A˚) 2.0 2.0
relative to helix H2 and appears unable to contact aObservations 229,657 239,994
base in the major groove of DNA. The difference in theUnique reflections 16,384 16,454
position of human p53 Lys120 and Cep-1 Lys237 con-Data coverage (%) 99.2 99.3
Rsym (%) 8.8 11.5 trasts with the fact that this lysine is invariant throughout
evolution in p53, p63, and p73 proteins, and even inPhasing Analysis (20.0–2.0 A˚)
amoeba p53 (Figure 2D). Further, with few exceptions,
Phasing power (centric) — 1.26 the two residues that surround this lysine (Ala236 and
Phasing power (acentric) — 1.44
Ser238 in Cep-1; Ala119 and Ser121 in human p53) areRcullis (centric) — 0.63
also invariant in evolution (Kaghad et al., 1997; SchmaleRcullis (acentric) — 0.74
and Bamberger, 1997; Derry et al., 2001; Schumacher
Refinement Statistics
et al., 2001; Brodsky et al., 2000; Mendoza et al., 2003).
Resolution range (A˚) 15.0–2.1 We examined the importance of Lys237 for DNA bind-
Reflections used (0 sigF) 14,247 ing using in vitro translated Cep-1 proteins in an electro-
Protein atoms 1,651 phoretic mobility shift assay. Our prior experience with
Zn atoms 1
human p53 suggests that in this assay DNA bindingWater molecules 155
requires p53 to be in its native oligomeric form (Water-R factor (%) 17.6
Rfree (%) 23.4 man et al., 1995). We therefore fused the DNA binding
Rms deviations domain of Cep-1 (residues 220–420), which by gel filtra-
Bonds (A˚) 0.010 tion analysis behaves as a monomer, to a C-terminal
Angles (o) 1.53 fragment of human p53 (residues 309–393) that contains
Ramachandran plot
the tetramerization domain and the epitope for antibodyMost favored (%) 90.8
PAb421. This fusion protein bound an oligonucleotideAllowed (%) 9.2
containing the p53 target site present in the promoter
Rsym  hi|Ih,i  Ih|/hiIh,i for the intensity (I) of i observations of of the cip1/waf1/p21 gene (El-Deiry et al., 1993), and thereflection h. Phasing power  Fi/E, where Fi is the root-
protein-DNA complex was supershifted with antibodymean-square heavy atom structure factor and E is the residual lack
PAb421, confirming that it contained the Cep-1 fusionof closure error. Rcullis  mean residual lack of closure error divided
by the dispersive difference. R factor  |Fobs  Fcalc|/| Fobs|, where protein (Figure 2E). Substitution of Lys237 with alanine
Fobs and Fcalc are the observed and calculated structure factors, clearly compromised DNA binding (Figure 2F). Since
respectively. Rfree  R factor calculated using 5% of the reflection both the wild-type and mutant Cep-1 fusion proteins
data chosen randomly and omitted from the start of refinement.
were expressed at similar levels (Figure 2G), we con-Rms deviations for bonds and angles are the respective root-mean-
clude that Lys237 is important for DNA binding.square deviations from ideal values.
The C-terminal half of loop L3 also adopts distinct
conformations in Cep-1 and human p53; in Cep-1 it is
-helical (helix Hc), while in human p53 it has no helical
The secondary structure elements of Cep-1 are shown secondary structure (Figures 2A and 2B). In human p53,
in Figure 1C, which also shows a structure-based align- this region contains two residues that are mutation hot-
ment of the amino acid sequences of the DNA binding spots in cancer: Arg248, which contacts the minor
domains of human p53 and Cep-1. Practically all the groove of DNA, and Arg249, which stabilizes the native
residues that are identical in human p53 and Cep-1 map structure of loops L2 and L3 by forming a salt bridge with
to parts of the structure where the human p53 and Cep-1 Glu171 from loop L2 (Figure 2A). Both these arginines
backbones overlay well when the two structures are are very highly conserved in evolution (Figure 2D). For
superimposed (Figure 1C; identical residues are indi- Arg248, this would be expected, since this residue con-
cated by vertical lines, residues whose C atoms are tacts DNA; for Arg249, the evolutionary conservation is
within 3.0 A˚ in the superimposed Cep-1 and human p53 harder to explain, since structural residues are typically
structures are colored red). Interestingly, there were two not so highly conserved through evolution. Arg248 and
exceptions to this general observation. Within loops L1 Arg249 of human p53 correspond to Arg371 and Arg372
and L3, there were residues that are conserved in evolu- of Cep-1, respectively. Arg371 adopts a conformation
tion but do not overlay when the structures are superim- similar to that of Arg248 of human p53. However, the
posed. This is because of the different conformations side chain of Arg372 does not point toward loop L2, as
adopted by loops L1 and L3 in human p53 and Cep-1. does the side chain of Arg249 of human p53, but rather
The main difference in the conformation of loop L1 it points in the same direction as the side chain of Arg371
between Cep-1 and human p53 is that in Cep-1 residues (Figures 2A and 2B). This suggested that Arg372 may
231–236 within the N-terminal half of the loop form helix contact DNA, and indeed, substitution of Arg372 with
Ha, whereas in human p53 the entire loop lacks helical alanine rendered Cep-1 incapable of binding DNA (Fig-
secondary structure (Figure 2A). Since the number of ures 2F and 2G).
amino acids that comprise loop L1 in the two proteins is The ability of Cep-1 to bind to the p53 target site in
the same (Figure 2D), the presence of helical secondary the promoter of the human cip1/waf1/p21 gene (Figure
2E) (Schumacher et al., 2001) indicates that Cep-1 andstructure only in Cep-1 leads to the tip of loop L1 adopt-
Differences in p53 and Cep-1
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Figure 1. Structure of Cep-1 DNA Binding Domain and Comparison to Human p53
(A and B) Ribbons representation of the Cep-1 (A) and human p53 (B) DNA binding domains shown in the same orientation. In the human
p53 structure (PDB ID 1TSR, chain B), helix H2 and the tip of loop L1 bind to the major groove of DNA, which is not shown in this figure.
Select secondary structure elements are labeled H1, H2, Ha, Hb, and Hc ( helices), L1, L2, and L3 (loops), and S10 ( strand). N, N terminus.
(C) Structure-based alignment of the sequences of Cep-1 and human p53 (hs_p53) DNA binding domains. Residues whose C atoms are
within 3.0 A˚ in the superimposed Cep-1 and human p53 structures are colored red. The numbering refers to codon positions of human p53
(above the aligned sequences) and Cep-1 (below the aligned sequences). Vertical lines, residues that are identical in human p53 and Cep-1;
z, residues that coordinate Zn; asterisks, residues of human p53 that contact DNA.
human p53 have similar DNA binding specificities. The has highest preference for A, lower preference for G and
C and no affinity for T (Figure 3B).optimal binding site for human p53 contains four nearly
identical tandem copies of the pentamer repeat se- The high similarity in DNA binding sequence specific-
ity between Cep-1 and human p53 suggested that thequence G-G-Pu-C-A (Pu, purine) arranged in a head-to-
tail orientation (Figure 3A) (El-Deiry et al., 1992; Halazo- residues of human p53 that contact DNA would be con-
served in Cep-1. In human p53, three residues contactnetis et al., 1993). We compared more carefully the DNA
binding specificities of Cep-1 and human p53 using oli- DNA bases: Lys120, Cys277, and Arg280 (Figures 3A
and 3C) (Cho et al., 1994). Arg280 in helix H2 contactsgonucleotides that differ from the optimal human p53
binding site by having the same single nucleotide substi- the invariant guanine at position 2	 of the pentamer re-
peat. The corresponding residue in Cep-1, Arg405, istution in each of the four pentamer repeats. Like human
p53, Cep-1 shows preference for purine at positions 5 expected to make a similar DNA contact. Cys277 of
human p53 contacts the cytosine at position 3	 of theand 3 of the repeat, requires cytosine at position 2, and
shows preference for adenine at position 1. The only pentamer repeat; the equivalent residue in Cep-1, Y402,
has a much bulkier side chain, raising concerns as todifference in DNA binding specificity related to position
4. Human p53 has equal preference for A and G, lower whether it can make a similar DNA contact. Finally,
Lys120 in loop L1 of human p53 contacts the guaninepreference for T, and no affinity for C, whereas Cep-1
Structure
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Figure 2. Comparison of the Loop L1 and L3
Structures of Cep-1 and Human p53
(A) Structure of loops L1 and L3 and adjacent
elements of Cep-1 and human p53 (hs_p53)
viewed in approximately the same orientation
as shown in Figure 1.
(B) Superimposition of Cep-1 and human p53
on the basis of the C atoms of the residues
that chelate Zn to show the different confor-
mations of loop L3 in the two proteins. The
views in (A) and (B) are related to each other
by a 90
 rotation along the y axis.
(C) Superimposition of Cep-1 and human p53
on the basis of the C atoms of the residues
of helix H2 to show the different conforma-
tions of loop L1 in the two proteins. The views
in (A) and (C) are related to each other by a
150
 rotation along the x axis. In the human
p53 structure (PDB ID 1TSR, chain B), helix
H2 and the tip of loop L1 bind to the major
groove of DNA, which is not shown in this
figure. The side chains of select residues are
labeled using the single letter amino acid
code and codon number, and select second-
ary structure elements are marked: loops L1,
L2, and L3;  helices H1, H2, Ha, Hb, and Hc;
and  strands S1, S2, and S10.
(D) Sequence alignment of the residues com-
prising loops L1 and L3 in various members
of the p53 protein family through evolution.
The boundaries for helices Ha and Hc refer
to Cep-1. Species are abbreviated as follows:
hs, Homo sapiens; xl, Xenopus laevis; om,
Oncorhyncus mykiss (trout); dm, Drosophila
melanogaster; ce, Caenorhabditis elegans;
eh, Entamoeba histolytica.
(E–G) DNA binding activity of Cep-1. (E) Bind-
ing of wild-type human p53 (hs_p53) and of
a protein containing the Cep-1 DNA binding
domain fused to the tetramerization domain
and C terminus of human p53 (Cep-1F) to the
p53 target site present in the cip1/waf1/p21
gene. RL, unprogrammed reticulocyte lysate.
(F) DNA binding of Cep-1F with a wild-type
(wt) Cep-1 DNA binding domain or a Cep-1
DNA binding domain in which Lys237 or
Arg372 was substituted with alanine (A237
and A372, respectively). (G) Autoradiogram of
the 35S-labeled in vitro translated human p53
and Cep-1F proteins used in the DNA binding
assays. The proteins were resolved by SDS-
polyacrylamide gel electrophoresis. RL, un-
programmed reticulocyte lysate.
at position 4 of the repeat. In Cep-1, the equivalent dimensional structure conservation. Yet surprisingly, the
structure of Cep-1 has several differences from the pre-residue, Lys237, adopts a significantly different position
because of the different loop L1 conformations in the viously solved human and mouse p53 structures (Cho
et al., 1994; Zhao et al., 2001), making it hard to under-two proteins (Figures 2C and 3C). This may explain the
different binding specificity of Cep-1 and human p53 for stand how these proteins have such similar DNA binding
specificities. The most interesting differences relate toposition 4 (Figure 3B). Overall, however, it is somewhat
surprising that Cep-1 and human p53 have identical the residues that contact DNA bases and the conforma-
tions of loops L1 and L3.DNA binding specificities at four out of five positions of
the pentamer repeat, even though only the DNA base Structural superimposition of the human p53 and
Cep-1 DNA binding domains reveals that of the threecontacts mediated by Arg280 of human p53 appear to
be conserved in Cep-1. human p53 residues that contact DNA bases (Lys120,
Arg280, and Cys277), only the contacts mediated by
Arg280 are likely to be conserved in Cep-1 (Figure 3).Discussion
This was unexpected given the similar DNA binding
specificity. One possible explanation for this finding isCep-1 and human p53 have remarkably similar DNA
binding specificities, predicting a high degree of three- that a significant fraction of the DNA binding specificity
Differences in p53 and Cep-1
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Figure 3. Comparison of the DNA Binding
Specificity of Cep-1 and Human p53 and Con-
servation of DNA Binding Residues of Human
p53 in Cep-1
(A) Nucleotide sequence of two of the four
tandem inverted pentamer repeats compris-
ing the optimal full-length binding site for hu-
man p53. The nucleotides are numbered ac-
cording to their position in the pentamer. The
human p53 residues that contact bases in the
first pentamer repeat are indicated next to
the nucleotide they contact.
(B) DNA binding specificiy of human p53
(hs_p53) and the Cep-1F fusion protein con-
taining the wild-type Cep-1 DNA binding do-
main fused to the human p53 tetramerization
domain and C terminus. Oligonucleotide BC
contains the optimal binding site for human
p53 shown in (A). Variants of oligonucleotide
BC contain one nucleotide substitution in
each pentamer repeat; the position of the
substitution and the variant nucleotide are
indicated. At position 3, the variant has a py-
rimidine (Py), instead of purine, such that the
sequence of two adjacent pentamer repeats
is GGTCA-TGGCC.
(C) Conservation of DNA binding residues of
human p53 in Cep-1. The side chains of the
human p53 residues that contact DNA and
the corresponding Cep-1 residues are indi-
cated. The atoms of DNA in contact with hu-
man p53 residues have the same color as the side chains of those residues. Ala276 contacts DNA through its amide nitrogen (shown as a
light blue sphere on the protein backbone). The side chain of Ala276, colored brown, does not contact DNA.
is contributed by residues that contact the DNA back- 2001). An explanation for these observations is not obvi-
ous from the structure of the human p53 DNA bindingbone. Several of the human p53 residues that contact
the DNA backbone are identical in Cep-1; specifically, domain, and unfortunately, the structure of Cep-1 does
not provide an answer either.human p53 residues Arg248, Arg273, and Ala276 corre-
spond to Cep-1 residues Arg371, Arg398, and Ala401, In human p53, loop L1 packs against helix H2, forming
a contiguous DNA binding surface that occupies therespectively (Figure 3C). Conservation of the contacts
mediated by Arg248 of human p53 could be particularly major groove of DNA (Figure 4A). Given that the lysine
at the tip of loop L1 is conserved in Cep-1 and humanimportant, since these contacts are likely to confer DNA
binding sequence specificity by requiring compression p53 and that this lysine contributes to DNA binding in
both proteins, we had expected that in Cep-1, helixof the DNA minor groove (Cho et al., 1994).
The second interesting difference relates to loop L3, H2 and loop L1 would form a contiguous DNA binding
surface similar to the one observed in human p53. How-which adopts different conformations in Cep-1 and hu-
man p53 (Figure 2B). The three-dimensional structure ever, this was not the case (Figure 4A). It is formally
possible that when Cep-1 binds DNA, loop L1 adopts adifference predicts that evolutionarily conserved resi-
dues have different roles in the two p53 proteins. Specifi- conformation similar to the one observed in human p53.
We think, however, that this is unlikely. There is no prec-cally, Arg249 in loop L3 of human p53 forms a salt bridge
with Glu171 that stabilizes the native structure of loop edent for a conformational switch of this magnitude
between the free and DNA-bound forms of human p53,L3 (Figure 2A); in Cep-1, the corresponding Arg372 most
likely contacts DNA as predicted by the three-dimen- which are practically identical to each other (Cho et al.,
1994; Zhao et al., 2001). Further, our attempts to modelsional structure and by the loss of DNA binding activity,
when this residue is substituted with alanine (Figure 2F). loop L1 of Cep-1 so that it adopts the same backbone
conformation as loop L1 of human p53 led to unresolv-The change in orientation of the side chain of Cep-1
Arg372 relative to human p53 Arg249 is due to the differ- able steric clashes with Cep-1 helix H2 residues. We
therefore favor the model that the DNA-bound form ofence in secondary structure in this region of loop L3; in
Cep-1 this region is -helical, but in human p53 it is Cep-1 adopts a conformation very similar to the one
observed in the absence of DNA. In this case, Lys237,random coil.
The most dramatic difference between the structures or any other residue in loop L1, would be unable to
contact bases in the major groove of DNA. In fact,of Cep-1 and human p53 is undoubtedly the conforma-
tion of loop L1. Loop L1 has previously attracted atten- Lys237 could not even make a DNA backbone contact
if Cep-1 were to bind DNA in exactly the same orientationtion because it is a cold spot for mutations in human
cancer and because substitutions targeting residues of as human p53 (Figure 4A). However, mutagenesis analy-
sis suggests that Lys237 contributes to Cep-1 DNA bind-loop L1 often enhance the affinity of human p53 for
specific DNA sequences (Saller et al., 1999; Inga et al., ing (Figure 2F). To determine whether the position of
Structure
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Figure 4. Structural Superimposition of Select Secondary Structure Elements and Residues of Cep-1, Human p53, and the Erythroid Transcrip-
tion Factor GATA-1
(A) Cep-1 and human p53 (hs_p53). (B) Cep-1 and GATA-1 (PDB ID 2GAT). (C) Cep-1, human p53 and GATA-1. Cep-1 is colored red, human
p53 and its bound DNA are colored blue, and GATA-1 and its bound DNA are colored green. The two views are related by a 90
 rotation along
the y axis, and the orientation in the top panel is similar to that shown in Figure 1. Cep-1 secondary structure elements: S10, strand 10; H2,
helix 2; L1, loop L1.
Experimental ProceduresLys237 is compatible with DNA binding, we structurally
superimposed helix H2 and residues Lys237 and Arg398
Protein Expression and Purificationof Cep-1 with the  helix and residues Arg177 and
The Cep-1 DNA binding domain (residues 220–420) was expressed
Arg199 of the chicken erythroid transcription factor in E. coli BL21 cells at 30
C. Cells were lysed in buffer consisting
GATA-1 (Omichinski et al., 1993). The superimposition of 25 mM bis-tris propane (BTP) (pH 6.8), 250 mM NaCl, 10 mM
DTT, and protease inhibitors, and the polypeptide was purified bywas remarkably good (Figure 4B). The  helix of GATA-1
cation exchange (Resource S column; Pharmacia) and gel filtrationbinds to the major groove of DNA, while the side chains
(Superdex 200 column; Pharmacia) chromatography. The proteinof residues Arg177 and Arg199 contact the phosphate
eluted from the gel filtration column in buffer consisting of 25 mMbackbone. If Cep-1 were to bind DNA like GATA-1, then
BTP (pH 6.8), 200 mM NaCl, and 10 mM DTT.
Cep-1 would adopt the more conventional DNA binding
motif of a single  helix in the major groove, and residues Crystallization and Data Collection
Arg398 and Lys237 would contact the phosphate back- Crystals were grown at room temperature by the hanging drop vapor
diffusion method by mixing the protein at 10 mg/ml with an equalbone (Figure 4B). In this case, the orientation of bound
volume of reservoir solution containing 0.8–1.1 M sodium citrate,DNA would differ from that observed in the human p53/
100 mM BTP (pH 9.2), 5% isopropyl alcohol (IPA), and 10 mM DTT.DNA complex (Figure 4C), and human p53 and Cep-1
Crystallization started at day 1, and crystals grew to their final size
would recognize the major groove of DNA via different over a 2–3 day period. The crystals formed in space group P212121
motifs: helix-loop for human p53 and helix only for with dimensions a 39.36 A˚, b 68.43 A˚, c 88.18 A˚, and contained
Cep-1. one molecule in the asymmetric unit. Heavy-atom derivatives were
obtained by soaking the crystals in harvest buffer (1.2 M sodiumIt is hard to fully reconcile the differences in the three-
citrate, 100 mM BTP [pH 9.2], and 5% IPA) supplemented withdimensional structures of Cep-1 and human p53 (resi-
0.5 mM mercury chloride, 1 mM -mercaptoethanol, and 5%–10%dues that contact DNA bases in human p53 are not
ethylene glycol for 2 hr. All data sets were collected using flash-
evolutionarily conserved in Cep-1, and loops L3 and L1 frozen crystals on a Rigaku R-AXIS IV imaging plate area detector
adopt different conformations) with the observation that mounted on a Rigaku rotating anode X-ray generator. Reflection
Cep-1 and human p53 have very similar DNA binding data were indexed, integrated, and scaled using the programs
DENZO and SCALEPACK (Otwinowski and Minor, 1997).specificities. We are proposing that Cep-1 and human
p53 differ in the way they recognize DNA. Yet, a high
Structure Determination and Refinementdegree of structural similarity would better explain the
The positions of four mercury atoms were calculated using the pro-conservation in DNA binding specificity. It is probably
gram SHELX (Schneider and Sheldrick, 2002). Phases were calcu-
fair to conclude that our understanding regarding how lated at 2.0 A˚ using the isomorphous signal of the heavy metal atoms
p53 proteins bind DNA through evolution is as yet incom- with the program MLPHARE (CCP4, 1994). The phases had a mean
figure of merit of 0.40 at 3.03 A˚ resolution (Table 1). After solventplete.
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flattening using DM (CCP4, 1994), the experimental electron density maps and the location of errors in these models. Acta Crystallogr.
A 47, 110–119.map showed clear density for all of the backbone and most side
chain atoms. An initial model was built with the program ARP/WARP Kaghad, M., Bonnet, H., Yang, A., Creancier, L., Biscan, J.C., Valent,
(Morris et al., 2002), improved by several cycles of manual rebuilding A., Minty, A., Chalon, P., Lelias, J.M., Dumont, X., et al. (1997).
with the program O (Jones et al., 1991), and refined with the program Monoallelically expressed gene related to p53 at 1p36, a region
CNS (Bru¨nger et al., 1998). Figures were prepared using the pro- frequently deleted in neuroblastoma and other human cancers. Cell
grams MOLSCRIPT, BOBSCRIPT, and RASTER3D (Kraulis, 1991; 90, 809–819.
Esnouf, 1997; Merritt and Bacon, 1997). Kraulis, P. (1991). Molscript: a program to produce both detailed
and schematic plots of protein structures. J. Appl. Crystallogr. 24,
DNA Binding Assays 946–950.
DNA binding was performed using in vitro translated proteins as
Mendoza, L., Orozco, E., Rodriguez, M.A., Garcia-Rivera, G., San-
previously described (Halazonetis et al., 1993; Waterman et al.,
chez, T., Garcia, E., and Gariglio, P. (2003). Ehp53, an Entamoeba
1995). The sequence of the oligonucleotide containing the p53 target
histolytica protein, ancestor of the mammalian tumour suppressor
site in cip1/waf1/p21 is CCC-GAACA-TGTCC-CAACA-TGTTG-GGG;
p53. Microbiol. 149, 885–893.
the sequence of oligonucleotide BC is CC-GGGCA-TGTCC-
Merritt, E.A., and Bacon, D.J. (1997). Raster3D—photorealistic mo-GGGCA-TGTCC-GGGCATGT.
lecular graphics. Methods Enzymol. 277, 505–524.
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